Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-05-10
2005-05-10
Le, Long V. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007900, C436S518000, C436S173000, C436S174000, C514S002600
Reexamination Certificate
active
06890722
ABSTRACT:
The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or the absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer, predict disease risk assessment, and develop therapeutic avenues against the disease.
REFERENCES:
patent: 5062935 (1991-11-01), Schlag et al.
patent: 6020208 (2000-02-01), Hutchens et al.
patent: 0 510 693 (1992-10-01), None
patent: WO 9014148 (1990-11-01), None
patent: WO 9324834 (1993-12-01), None
patent: WO 9807036 (1998-02-01), None
patent: WO0020840 (2000-04-01), None
patent: WO02088742 (2002-11-01), None
patent: WO02088746 (2002-11-01), None
D. Kutter et al, “Screening for Oligoalbuminuria by Means of Micral-Test II a New Immunological Test Strip”, Eur. J. Clin. Chem. Clin. Biochem., 33(4):243-244 (Apr., 1995).
T. Kawakami et al, “NEDO Human cDNA Sequencing Project”, Database EMBL Accession No. Q9H5Y8, XP-002257049 (Mar., 2001).
Takahashi et al., “Rapid and Sensitive Immunoassay for the Measurement of Serum S100β Using Isoform-specific Monoclonal Antibody”, Clinical Chemistry 45, No. 8, (1999) pp. 1307-1311.
Richter et al., “Composition of the peptide fraction in human blood plasma: database of circulating human peptides”, Journal of Chromatography B; 726 (1999) pp. 25-35.
Jackowski George
Marshall John
Davis Deborah A
Le Long V.
McHale & Slavin P.A.
Syn X Pharma, Inc.
LandOfFree
HP biopolymer markers predictive of insulin resistance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HP biopolymer markers predictive of insulin resistance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HP biopolymer markers predictive of insulin resistance will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3435698